Provectus Biopharmaceuticals PVCT
OTC PVCT
$0.05 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Provectus Biopharmaceuticals (PVCT) Cash from Investing Activities (2012 - 2017)

Updated

Provectus Biopharmaceuticals' Cash from Investing Activities came in at -$4,761 for Q4 2017.

Analysis

Provectus Biopharmaceuticals (PVCT) Cash from Investing Activities (2012 - 2017) Analysis & Trends

For FY2017, Provectus Biopharmaceuticals' Cash from Investing Activities was -$30,400.

  • Going back by year, Cash from Investing Activities was -$6,139 in FY2015, -$70,590 in FY2014 and -$6,650 in FY2013.
  • The Q4 2017 figure represents the lowest quarterly Cash from Investing Activities since Q3 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn -2.71 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -1.20 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn -2.91 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -10.35 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 2.11 Bn
10 Provectus Biopharmaceuticals 21.01 Mn 19.10 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 -4,761.00
Sep 30, 2015 -6,139.00
Sep 30, 2014 -70,590.00
Mar 31, 2012 -15,885.00
API Access

Provectus Biopharmaceuticals Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=PVCT&period=max&api_key=YOUR_API_KEY